HUALAN BIOLOGICAL ENGINEERING INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.03 CNY | +0.53% |
|
+1.28% | -14.01% |
| Apr. 02 | Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates | MT |
| Apr. 01 | Hualan Biological Engineering Inc. Proposes Profit Distribution for 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hualan Biological Engineering, Inc. specializes in the research, development, manufacturing and marketing of biological and sanguine products and vaccines. The group's products include immunoglobulin for intravenous injections, lyophilized surgical fibrin, lyophilized thrombin for external use, vaccines against cold, etc.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
19.03
CNY
Average target price
25.78
CNY
Spread / Average Target
+35.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.01% | 4.81B | |
| -5.99% | 83.66B | |
| +2.76% | 40.41B | |
| -24.88% | 28.26B | |
| +53.61% | 24.53B | |
| -8.08% | 16.82B | |
| -33.74% | 13.39B | |
| -16.63% | 11.75B | |
| -11.19% | 11.69B | |
| -2.25% | 8.13B |
- Stock Market
- Equities
- 002007 Stock
- News Hualan Biological Engineering Inc.
- Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug
